Product Name: Coluracetam
Synonyms: COLURACETAM;N-(2,3-Dimethyl-5,6,7,8-tetrahydrofuro [2,3-b] quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide;1-Pyrrolidineacetamide,2-oxo-N-(5,6,7,8-tetrahydro-2,3-dimethylfuro [2,3-b] quinolin-4-yl)-;Coluracetam, MKC-231;1- [N-(2,3-DiMethyl-5,6,7,8-tetrahydrofuro [2,3-b] quinolin-4-yl)carbaMoylMethyl] pyrrolidin-2-one;BCI-540;Coluracetam, >=99%;2-oxo-N-(5,6,7,8-tetrahydro-2,3-dimethyl-furo [2,3-b] quinolin-4-yl)-1-pyrrolidineacetamide
CAS: 135463-81-9
MF: C19H23N3O3
MW: 341.4
EINECS: 1308068-626-2
Product Categories: Brain health drug;Nootropic;pharmaceutical intermediate or medicine grade;pharmaceutical
Mol File: 135463-81-9.mol
Coluracetam Structure
Coluracetam Chemical Properties
Boiling point  634.1±55.0 °C(Predicted)
density  1.291±0.06 g/cm3(Predicted)
storage temp.  Sealed in dry,Room Temperature
solubility  DMF: 1 mg/ml; DMSO: 2 mg/ml; Ethanol: 2 mg/ml; PBS (pH 7.2): insol
form  A crystalline solid
pka 12.01±0.20(Predicted)
color  White to off-white
InChI InChI=1S/C19H23N3O3/c1-11-12(2)25-19-17(11)18(13-6-3-4-7-14(13)20-19)21-15(23)10-22-9-5-8-16(22)24/h3-10H2,1-2H3,(H,20,21,23)
InChIKey PSPGQHXMUKWNDI-UHFFFAOYSA-N
SMILES N1(CC(NC2C3=C(N=C4OC(C)=C(C)C4=2)CCCC3)=O)CCCC1=O
Safety Information
MSDS Information
Coluracetam Usage And Synthesis
Uses Copiracetam can be used as a nootropic drug to treat memory and intellectual impairments caused by senile dementia, mild to moderate vascular dementia, trauma and other diseases, and to promote children's intellectual development; it also has antidepressant effects.
Pharmacology Copiracetam has the ability to improve cognition by participating in the HACU process, increasing the rate-limiting step of synaptic intake of choline to synthesize the neurotransmitter acetylcholine, and increasing the activity of cholinergic neurons.
in vitro Coluracetam (10(-10)-10(-6) moll), also known as MKC-231, significantly increased high affinity choline uptake (HACU) when it was incubated with the hippocampal synaptosomes of ethylcholine mustard aziridinium ion (AF64A) treated rats, but not of normal rats. MKC-231 did not affect the AChE activity, [3H] - quinuclidinyl benzilate binding, and [3H] -pirenzepine binding.
in vivo Oral administration of MKC-231 (Coluracetam; 1-10 mg/kg) significantly improved the learning deficits in the Morris' water maze of AF64A-treated rats, but it did not produce any significant side effects, like tremor, salivation or hypothermia, which were observed in rats treated with high doses of tacrine [1] . In acute behavioral experiments, MKC-231 and THA had no significant effect on AF64A-induced memory deficits at any doses tested (0.3, 1.0 and 3.0 mg/kg), whereas Dup 996, at a dose of 1.0 mg/kg, significantly improved memory deficits. In chronic experiments, MKC-231 improved memory deficit at all doses tested (0.3, 1.0, or 3.0 mg/kg p.o., once daily for 11 days) and Dup 996 did so only at a dose of 3.0 mg/kg, whereas THA did not improve memory deficit at any doses tested.